Cargando…

The Dual Role of CCR5 in the Course of Influenza Infection: Exploring Treatment Opportunities

Influenza is one of the most relevant respiratory viruses to human health causing annual epidemics, and recurrent pandemics. Influenza disease is principally associated with inappropriate activation of the immune response. Chemokine receptor 5 (CCR5) and its cognate chemokines CCL3, CCL4 and CCL5 ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrero, Maximiliano Ruben, Tavares, Luciana Pádua, Garcia, Cristiana Couto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810482/ https://www.ncbi.nlm.nih.gov/pubmed/35126379 http://dx.doi.org/10.3389/fimmu.2021.826621

Ejemplares similares

Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
por: Fantuzzi, Laura, et al.
Publicado: (2019)

CCR5 Antagonist Maraviroc Inhibits Acute Exacerbation of Lung Inflammation Triggered by Influenza Virus in Cigarette Smoke-Exposed Mice
por: Ferrero, Maximiliano Ruben, et al.
Publicado: (2021)

Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors
por: Salomonsson, Maya, et al.
Publicado: (2020)

CCR4 and CCR5 Involvement in Monocyte-Derived Macrophage Migration in Neuroinflammation
por: Kim, Jong Youl, et al.
Publicado: (2022)

CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab
por: Chang, Xiao L., et al.
Publicado: (2021)

Novel Immunomodulatory Therapies for Respiratory Pathologies
por: Tavares, Luciana Pádua, et al.
Publicado: (2022)

The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)

CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection
por: Tavares, Luciana P., et al.
Publicado: (2017)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

CCR5 and HIV Infection, a View from Brussels
por: Parmentier, Marc
Publicado: (2015)

Editorial: CCR5: A receptor at the center stage in infection
por: Ellwanger, Joel Henrique, et al.
Publicado: (2022)

Natural Killer Cell Recruitment to the Lung During Influenza A Virus Infection Is Dependent on CXCR3, CCR5, and Virus Exposure Dose
por: Carlin, Lindsey E., et al.
Publicado: (2018)

Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5–CCR5 axis
por: Mukanova, Saida, et al.
Publicado: (2022)

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022)

Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
por: Van Der Ryst, Elna
Publicado: (2015)

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
por: Mohamed, Hager, et al.
Publicado: (2022)

Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1
por: Platt, Emily J., et al.
Publicado: (2015)

Hallmarks of the relationship between host and Trypanosoma cruzi sulfated glycoconjugates along the course of Chagas disease
por: Soprano, Luciana L., et al.
Publicado: (2023)

CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice
por: Mattos, Matheus Silverio, et al.
Publicado: (2020)

Filling the Gaps in Antagonist CCR5 Binding, a Retrospective and Perspective Analysis
por: Amerzhanova, Yerkezhan, et al.
Publicado: (2022)

Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy
por: Kwiatkowski, Klaudia, et al.
Publicado: (2020)

Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview
por: Junker, Anna, et al.
Publicado: (2014)

CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor
por: Zilio, Serena, et al.
Publicado: (2022)

CCR5 Promoter Polymorphisms Associated With Pulmonary Tuberculosis in a Chinese Han Population
por: Liu, Shuyuan, et al.
Publicado: (2021)

Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers
por: Picton, Anabela C. P., et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
por: Qiu, Yue, et al.
Publicado: (2021)

Skewed Lung CCR4 to CCR6 CD4(+) T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function
por: Adegunsoye, Ayodeji, et al.
Publicado: (2016)

Corrigendum: Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
por: Qiu, Yue, et al.
Publicado: (2021)

Exploring Dual Pathology: Opportunities and Challenges
por: Cuartas-Arias, Mauricio
Publicado: (2023)

Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
por: She, Shaoping, et al.
Publicado: (2022)

Evidence for a Role of CCR6+ T Cells in Chronic Thromboembolic Pulmonary Hypertension
por: van Uden, Denise, et al.
Publicado: (2022)

Divergent Expression of CXCR5 and CCR5 on CD4(+) T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection
por: Zaunders, John, et al.
Publicado: (2017)

The Role of MECP2 and CCR5 Polymorphisms on the Development and Course of Systemic Lupus Erythematosus
por: Rzeszotarska, Ewa, et al.
Publicado: (2020)

Antibodies Against Conserved Antigens Provide Opportunities for Reform in Influenza Vaccine Design
por: Kaminski, Denise A., et al.
Publicado: (2011)

The Chemokine Receptor CCR5 Links Memory CD4(+) T Cell Metabolism to T Cell Antigen Receptor Nanoclustering
por: Blanco, Raquel, et al.
Publicado: (2021)

CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population
por: Kulmann-Leal, Bruna, et al.
Publicado: (2021)

Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis
por: Cantanhede, Isabella Gomes, et al.
Publicado: (2022)

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
por: Lefebvre, Eric, et al.
Publicado: (2016)

Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19
por: Files, Daniel Clark, et al.
Publicado: (2022)

CCR4 and CCR7 differentially regulate thymocyte localization with distinct outcomes for central tolerance
por: Li, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7d9e7dtf8kg2rvmg27j50ntil5